Respiratory therapy

Global Non-invasive Ventilators Market - Industry Analysis, Size, Share, Growth, Trends & Forecasts 2017-2019 & 2027 - ResearchAndMarkets.com

Monday, November 18, 2019 - 7:59pm

The "Non-invasive Ventilators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Non-invasive Ventilators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027" report has been added to ResearchAndMarkets.com's offering.
  • This recent study on the non-invasive ventilators market offers its audience a holistic market outline with the help of a comprehensive evaluation of the global non-invasive ventilators industry.
  • The next section in the non-invasive ventilators market study is the market overview, which offers a glimpse of the market with respect to the key non-invasive ventilators market dynamics such as market drivers, future opportunities, and challenging factors.
  • The unique dashboard view of the players in the non-invasive ventilators market report aids readers in understanding the strategies implemented by key players and their performance in the non-invasive ventilators market, comprising focus areas of the non-invasive ventilators market players.

Gofire Launches Patented, Metered-dose Inhaler to Vaporization Market Seeking Safe, Accurate Dose Control

Thursday, November 14, 2019 - 2:00pm

Our Gofire Inhaler offers the most accurate, metered-dose experience available for plant medicine while providing protections against the conditions that have created health concerns among vaporization users.

Key Points: 
  • Our Gofire Inhaler offers the most accurate, metered-dose experience available for plant medicine while providing protections against the conditions that have created health concerns among vaporization users.
  • As part of its rigorous development process, the Gofire Inhaler has been proving itself as an effective tool for medical dose management throughout 2019.
  • Together, the Gofire Inhaler and Gofire App create a smart health ecosystem enabling the precise dosage and replicable experience patients and physicians have been seeking from alternative medicines.
  • Gofire is committed to making health resources safe and accessible through standardizing dose regimens by delivery method and by patient condition.

Digital Dose Inhalers Market 2019-2023- Evolving Opportunities with AstraZeneca and GlaxoSmithKline | Technavio

Thursday, November 14, 2019 - 10:30am

The global digital dose inhalers market size will grow by USD 989.44 million during 2019-2023.

Key Points: 
  • The global digital dose inhalers market size will grow by USD 989.44 million during 2019-2023.
  • This market report provides a detailed analysis of the market by product (metered dose and soft mist inhalers; and dry powder inhalers) and geography (Asia, Europe, North America, and ROW).
  • GlaxoSmithKline Plc is another leading vendor in the digital dose inhalers market sphere.
  • Novartis AG is also a leading vendor in the digital dose inhalers market.

Fifth Season Financial Offers Resources for COPD Patients Facing Financial Hardship

Wednesday, November 13, 2019 - 5:27pm

Recognizing National COPD Awareness Month this November, specialty lender Fifth Season Financial has developed an online resource for patients as well as a solution to help alleviate the financial strain associated with COPD and other advanced-stage illnesses.

Key Points: 
  • Recognizing National COPD Awareness Month this November, specialty lender Fifth Season Financial has developed an online resource for patients as well as a solution to help alleviate the financial strain associated with COPD and other advanced-stage illnesses.
  • Fifth Season Financial's new blog post, Financial Solutions for Patients with Chronic Obstructive Pulmonary Disease (COPD) , includes information on programs available to help minimize patients' financial challenges.
  • "Coping with a serious illness can drain savings and rack up bills swiftly," said Fifth Season Financial president Adam Balinsky.
  • Fifth Season has provided over $190 million in financial assistance to more than 600 patients across the United States.

Global Asthma Spacers Market 2019-2023 | Evolving Opportunities with ALLERGAN & Cipla | Technavio

Wednesday, November 13, 2019 - 11:30am

View the full release here: https://www.businesswire.com/news/home/20191113005363/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20191113005363/en/
    Technavio has announced its latest market research report titled global asthma spacers market 2019-2023.
  • Also, the increase in online retail is anticipated to further boost the growth of the asthma spacers market.
  • The growing demand for respiratory care is expected to drive the growth of the global asthma spacers market.
  • Allergy, pollution, and smoking can result in several respiratory diseases such as obstructive airway diseases like asthma, COPD, and cystic fibrosis.

Airway Clearance Systems Market Size Worth $698.11 Million by 2026: Grand View Research, Inc.

Wednesday, November 13, 2019 - 11:05am

SAN FRANCISCO, Nov. 13, 2019 /PRNewswire/ -- The global airway clearance systems market size is expected to reach USD 698.11 million by 2026, registering a CAGR of 4.5%over the forecast period, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, Nov. 13, 2019 /PRNewswire/ -- The global airway clearance systems market size is expected to reach USD 698.11 million by 2026, registering a CAGR of 4.5%over the forecast period, according to a new report by Grand View Research, Inc.
  • Rising adoption of clearance system to curb the surmounting prevalence of cystic fibrosis, Chronic Obstructive Pulmonary Disease (COPD), bronchiectasis is the primary market driver.
  • Key players operating in the airway clearance systems market are Hill-Rom Holdings, Inc.; Electromed Inc.; Aptalis Pharma U.S. Inc.; and Thayer Medical.
  • Grand View Research has segmented the global airway clearance systems market based on device type, application, end use, and region:
    Airway Clearance Systems Device Type Outlook (Revenue, USD Million, 2014 - 2026)
    Airway Clearance Systems Application Outlook (Revenue, USD Million, 2014 - 2026)

Airway Clearance Systems Market Size Worth $698.11 Million by 2026: Grand View Research, Inc.

Wednesday, November 13, 2019 - 11:05am

SAN FRANCISCO, Nov. 13, 2019 /PRNewswire/ -- The global airway clearance systems market size is expected to reach USD 698.11 million by 2026, registering a CAGR of 4.5%over the forecast period, according to a new report by Grand View Research, Inc.

Key Points: 
  • SAN FRANCISCO, Nov. 13, 2019 /PRNewswire/ -- The global airway clearance systems market size is expected to reach USD 698.11 million by 2026, registering a CAGR of 4.5%over the forecast period, according to a new report by Grand View Research, Inc.
  • Rising adoption of clearance system to curb the surmounting prevalence of cystic fibrosis, Chronic Obstructive Pulmonary Disease (COPD), bronchiectasis is the primary market driver.
  • Key players operating in the airway clearance systems market are Hill-Rom Holdings, Inc.; Electromed Inc.; Aptalis Pharma U.S. Inc.; and Thayer Medical.
  • Grand View Research has segmented the global airway clearance systems market based on device type, application, end use, and region:
    Airway Clearance Systems Device Type Outlook (Revenue, USD Million, 2014 - 2026)
    Airway Clearance Systems Application Outlook (Revenue, USD Million, 2014 - 2026)

Verona Pharma to Present at Jefferies 2019 London Healthcare Conference

Wednesday, November 13, 2019 - 7:00am

This year marks the 10th anniversary of The Jefferies 2019 London Healthcare Conference, now one of the largest healthcare-dedicated conference in Europe.

Key Points: 
  • This year marks the 10th anniversary of The Jefferies 2019 London Healthcare Conference, now one of the largest healthcare-dedicated conference in Europe.
  • In 2018, 500 companies and 2,000 attendees participated in the conference, which featured 5,000 business-to-business and investor meetings.
  • Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs.
  • Verona Pharma is currently in Phase 2 development of three formulations of ensifentrine for the treatment of COPD: nebulized, dry powder inhaler, and pressurized metered-dose inhaler.

Optinose Reports Third Quarter 2019 Financial Results and Recent Operational Highlights

Tuesday, November 12, 2019 - 9:01pm

Conference call and webcast to be held today at 4:30 p.m. Eastern Time

Key Points: 
  • Conference call and webcast to be held today at 4:30 p.m. Eastern Time
    YARDLEY, Pa., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported financial results for the quarter ended September30, 2019, and provided recent operational highlights.
  • The number of XHANCE (fluticasone propionate) prescriptions increased by 27% from second quarter to third quarter 2019 and by 18% from September to October 2019.
  • The Company generated $8.7 million and $19.3 million of XHANCE net revenue during the three-month and nine-month periods ended September30, 2019.
  • Selling, general and administrative expenses were $25.3 million and $77.6 million during the three-month and nine-month periods ended September30, 2019.

Monaghan Medical Corporation Wins Prestigious Zenith Award from the American Association of Respiratory Care

Tuesday, November 12, 2019 - 1:45pm

PLATTSBURGH, N.Y., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation (MMC) has received the prestigious American Association of Respiratory Care (AARC) Zenith Award for the fifth consecutive year.

Key Points: 
  • PLATTSBURGH, N.Y., Nov. 12, 2019 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation (MMC) has received the prestigious American Association of Respiratory Care (AARC) Zenith Award for the fifth consecutive year.
  • The award was presented at the 65th International Respiratory Care Convention and Exhibition in New Orleans, Louisiana.
  • The Zenith Award is a peoples choice award of excellence voted on annually by members of the respiratory care profession.
  • Recipients are selected based on such criteria as outstanding service, quality, accessibility, truth in advertising and support of the respiratory care community.